VOLITIONRX LTD — Director's Dealing 2022

Aug 5, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2022-08-03-05:00

Reporting Person: Micallef Jacob Vincent (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-03-05:00	Common Stock	F	4825	$1.97	Disposed	120228	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	22000	Indirect
Common Stock	38113	Indirect

Footnotes

F1: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,063 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction

F2: The shares of common stock are held directly by Borlaug Limited. The reporting person is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of common stock held by Borlaug Limited.